ATE469970T1 - Plasmidvektor - Google Patents

Plasmidvektor

Info

Publication number
ATE469970T1
ATE469970T1 AT00922897T AT00922897T ATE469970T1 AT E469970 T1 ATE469970 T1 AT E469970T1 AT 00922897 T AT00922897 T AT 00922897T AT 00922897 T AT00922897 T AT 00922897T AT E469970 T1 ATE469970 T1 AT E469970T1
Authority
AT
Austria
Prior art keywords
integrase
plasmid vector
dna
segment
components
Prior art date
Application number
AT00922897T
Other languages
English (en)
Inventor
Atsushi Katsumata
Sumio Hoshi
Takeshi Ihara
Susumu Ueda
Original Assignee
Nippon Inst For Biolog Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Inst For Biolog Science filed Critical Nippon Inst For Biolog Science
Application granted granted Critical
Publication of ATE469970T1 publication Critical patent/ATE469970T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/30—Bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT00922897T 1999-06-04 2000-04-27 Plasmidvektor ATE469970T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15835199 1999-06-04
PCT/JP2000/002785 WO2000075342A1 (fr) 1999-06-04 2000-04-27 Nouveau vecteur plasmidique

Publications (1)

Publication Number Publication Date
ATE469970T1 true ATE469970T1 (de) 2010-06-15

Family

ID=15669764

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00922897T ATE469970T1 (de) 1999-06-04 2000-04-27 Plasmidvektor

Country Status (6)

Country Link
US (1) US6936465B1 (de)
EP (1) EP1103614B1 (de)
AT (1) ATE469970T1 (de)
AU (1) AU4315000A (de)
DE (1) DE60044488D1 (de)
WO (1) WO2000075342A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024916A1 (en) * 2000-09-20 2002-03-28 Takara Bio Inc. Complex
AU2003254929A1 (en) * 2002-08-13 2004-03-03 Kaneka Corporation Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained
WO2004080162A2 (en) * 2003-03-07 2004-09-23 Avigenics, Inc. Integrase mediated avian transgenesis
EP1733034A4 (de) * 2004-03-15 2010-01-20 Biogen Idec Inc Verfahren und konstrukte zur expression von polypeptidmultimeren in eukaryontischen zellen unter vewendung von alternativem spleissen
WO2006035687A1 (ja) * 2004-09-28 2006-04-06 Kaneka Corporation 遺伝子導入鳥類作製法
US7892810B2 (en) * 2006-09-15 2011-02-22 University Of Maryland, Baltimore Corynephage integrase-based site-specific insertion vector system
WO2016073559A1 (en) * 2014-11-05 2016-05-12 The Regents Of The University Of California Methods for autocatalytic genome editing and neutralizing autocatalytic genome editing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9700560A (es) 1994-08-05 1997-05-31 Warner Lambert Co Metodo de uso de integrasa retroviral negativa transdominante en el tratamiento de infecciones retrovirales.
AU5741996A (en) * 1995-05-22 1996-12-11 Chiron Corporation Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
DE19530412A1 (de) * 1995-08-18 1997-02-20 Harald Von Prof Dr Melchner Selbst deletierende retrovirale Vektoren für die Gentherapie

Also Published As

Publication number Publication date
US6936465B1 (en) 2005-08-30
AU4315000A (en) 2000-12-28
DE60044488D1 (de) 2010-07-15
EP1103614B1 (de) 2010-06-02
WO2000075342A1 (fr) 2000-12-14
EP1103614A4 (de) 2002-02-27
EP1103614A1 (de) 2001-05-30

Similar Documents

Publication Publication Date Title
PL1824977T3 (pl) Promotorowy kwas nukleinowy pochodzący z rodzaju Corynebacterium, kaseta ekspresyjna zawierająca promotor i wektor, komórka gospodarza zawierająca wektor i sposób ekspresji genu z użyciem komórki
TWI319008B (en) Multiple inducible gene regulation system
DE60025037D1 (de) "functional genomics" unter verwendung von zink finger proteinen
WO1995034668A3 (en) The cytoplasmic inhibition of gene expression
WO1994025612A3 (fr) Sequences de nucleotides pour le controle de l'expression de sequences d'adn dans un hote cellulaire
CA2398473A1 (en) Multi zone cracking furnace
DK0939763T3 (da) Styret skift-medieret DNA-rekombination
AU3372799A (en) Methods for exogenous, internal controls during nucleic acid amplification
EP1471926B8 (de) Zusammensetzungen und verfahren zur therapeutischen anwendung einer mit dem gen atonal assoziierten sequenz
DE69435218D1 (de) Regulation der Genexpression von bcl-2
DE60044488D1 (de) Plasmidvektor
WO2002031137A3 (en) Cytomegalovirus intron a fragments
ATE342998T1 (de) Replikation -defektive baculoviren expressionssystem
AU2002361951A1 (en) Genes of corynebacterium glutamicum encoding for genetic stability, gene expression and folding proteins
AU3159501A (en) Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof
AU689803B2 (en) Plant-derived phospholipase D gene
AU4903099A (en) Targeted integration into chromosomes using retroviral vectors
WO2002081650A3 (en) Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast
WO2001053474A3 (en) Flavobacterium heparinum expression system
AU2003278603A1 (en) Hm1.24-utilizing cancer vaccines
AU2003259185A1 (en) Process for regulating gene expression
DE69938427D1 (de) Tes gen und dessen verwendung
AU2002322911A1 (en) Use of alphacp1, alphacp2, and hur for modulating gene expression and inducing angiogenesis
ATE371032T1 (de) Methoden und materialien fur genexpression
WO2003061581A3 (en) Compositions and methods for regulating rna stability using polypyrimidine tract proteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties